I. Petry

Role of urokinase-type plasminogen activator (uPA) and plasminogen activator inhibitor type 1 (PAI-1) for prognosis in endometrial cancer.

D. Hasenclever, E. Steiner, A. Puhl, 2008, Gynecologic oncology.

p53 is correlated with low BMI negative progesterone receptor status and recurring disease in patients with endometrial cancer.

H. Kölbl, D. Böhm, E. Steiner, 2012, Gynecologic oncology.